One hundred seventy two deaths involving the use of oxycodone in Palm Beach County

Journal of Forensic Sciences

Volumn 50, Issue 1, 2005, Pages 192-195

  Wolf, Barbara C ^a,d   Lavezzi, Wendy A ^b   Sullivan, Linda M ^c   Flannagan, Lisa M ^a  

^a Office of the Medical Examiner   (United States)

^b ALBANY MEDICAL CENTER   (United States)

^c Wuesthoff Reference Laboratories   (United States)

^d Department of Hand Surgery   (United States)

Author keywords

Death; Drug concentrations; Forensic science; Oxycodone; Toxicology

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; COCAINE; OXYCODONE;

AUTOPSY; CAUSE OF DEATH; DRUG ABUSE; DRUG BLOOD LEVEL; FATALITY; FORENSIC IDENTIFICATION; HUMAN; INJURY; MORTALITY; PAIN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

EID: 11844255483     PISSN: 00221198     EISSN: None     Source Type: Journal    
DOI: 10.1520/jfs2004194     Document Type: Review

References (18)

1. Anderson DT, Fritz KL, Muto JJ. Oxycontin: The concept of a "ghost pill" and the postmortem tissue distribution of oxycodone in 36 cases. J Anal Toxicol 2002;26:448-59.
2. Baselt RC. Oxycodone. In: Baselt RC, editor. 5th ed. Disposition of toxic drugs and chemicals in man. Chemical Toxicology Institute, Foster City, CA: 2000:644-5.
3. Suffett WL. Oxycontin abuse. J KY Med Assoc 2001;99:72.
4. Young D. Federal reports say oxycodone abuse is on the rise. Am J Health Syst Pharm 2001;58:1175-9.
5. Spake A. Not an appropriate use. Did the makers of Oxycontin push too hard. US New World Rep 2001;131:26.
6. Drummer OH, Syrjanen ML, Phelan M, Cordner SM. A study of deaths involving oxycodone. Forensic Sci 1994;39:1069-75.
7. Cone EJ, Fant RV, Rohay JM, Caplan YH, Ballina M, Reder RF, et al. Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases. J Anal Toxicol 2003;27:57-67.
8. Spiller AA. Postmortem oxycodone and hydrocodone blood concentration. J Forensic Sci 2003;48:429-31.
9. Davis MP, Varga J, Dickerson D, Walsh D, LeGrand SB, Lagman R. Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy. Support Care Cancer 2003;11:84-92.
10. Rooney S, Kelly G, Bamford L, Sloan D, O'Connor JJ. Co-abuse of opiates and benzodiazepines. Ir J Med Sci 1999;168:36-41.
11. Cremese M, Wu AH, Cassella G, O'Connor E, Rymut K, Hill DW. Improved GC/MS analysis of opiates with use of oxime- TMS derivatives. J Forensic Sci 1998;43:1220-4.
12. United Chemical Technologies, Inc. Product application. Opiates by GC/MS. Bristol, PA: United Chemical Technologies, Inc.
13. Cone EJ, Fant RV, Rohay JM, Caplan YH, Ballina M, Reder RF, et al. Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions. J Anal Toxicol 2004;28:217-25.
14. Clayton RR. Multiple drug use. Epidemiology, correlates, and consequences. Recent Dev Alcohol 1986;4:7-38.
15. Davoli M, Perucci CA, Forastiere P, Doyle E, Rapiti E, Zaccarelli M, Abeni DD. Risk factors for overdose mortality: a case-control study within a cohort of intravenous drug users. Int J Epidemiol 1993;22:273-7.
16. Quinn DI, Wodak A, Day RO. Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users. Clin Pharmacokinetic 1997;33:344-400.
17. Wolf BC, Lavezzi WA, Sullivan LM, Flannagan LM. Methadone-related deaths in Palm Beach County. J Forensic Sci 2004;49:375-8.
18. Dalpe-Scott M, Degouffe M, Garbutt D, Drost M. A comparison of drug concentrations in postmortem cardiac and peripheral blood in 320 cases. Can Soc For Sci J 1995;28:113-21.